Observation of Initial Procalcitonin and the Clinical Course of Patients With Acute Respiratory Tract Infections

Observation of the Initial Procalcitonin Values and the Clinical Course of Patients With Acute Respiratory Tract Infections at General Medical Practices in Greater Hannover

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00827060

Enrollment

702

Registered

2009-01-22

Start date

2006-12-31

Completion date

2007-09-30

Last updated

2009-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Tract Infections

Keywords

primary care, procalcitonin, acute respiratory tract infection

Brief summary

Observation of the initial Procalcitonin values and the clinical course of consecutively included patients with Acute Respiratory Tract Infections at general medical practices in greater Hannover.

Detailed description

Primary endpoint: * initial Procalcitonin values of patients with Acute Respiratory Tract Infections Secondary endpoints: * correlation of initial Procalcitonin values to classify Acute Respiratory Tract Infections * correlation of initial Procalcitonin values to subjective severity of Acute Respiratory Tract Infections * correlation of initial Procalcitonin values to antibiotic- prescriptions * correlation of initial Procalcitonin values to frequency of admission to hospital * correlation of initial Procalcitonin values to frequency of referrals (radiology, pneumology)

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* written informed consent * all types of respiratory tract infection according to investigator´s diagnosis

Exclusion criteria

* pretreatment with antibiotics in the past 2 weeks * portal hypertension * Major surgeries or multiple trauma which require hospitalization, in previous 4 weeks * Autoimmune disease and systemic diseases (lupus erythematodes, wegener´s disease) * Peritoneal dialysis * Acute treated or recently operated medullary c-cell-carcinoma, SCLC, carcinoid * Other inflammatory diseases (e.g. urinary tract infection, pyelonephritis, pancreatitis

Countries

Germany

Outcome results